Učitavanje...
Toxicity management of immunotherapy for patients with metastatic melanoma
Checkpoint inhibitors have revolutionized the treatment of patients with metastatic melanoma offering improved responses and significant survival benefit. These agents are now approved for the treatment of metastatic melanoma, squamous and non-squamous non-small cell lung cancer (NSCLC) and kidney c...
Spremljeno u:
| Izdano u: | Ann Transl Med |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4971373/ https://ncbi.nlm.nih.gov/pubmed/27563659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.07.10 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|